VTX958 for the Treatment of Moderately to Severely Active Crohn's Disease

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
This is a multicenter, randomized, double-blind placebo-controlled, parallel group study to evaluate the efficacy and safety of VTX958 in participants with moderately to severely active Crohn\'s Disease.
Epistemonikos ID: beb949a250cf60b4b49a853c6de7ab6ebed56800
First added on: Feb 19, 2024